Ankasa Regenerative Therapeutics
0 followers
Ankasa is developing ART352-L as a novel regenerative medicine. Successful development of ART352-L will enhance the osteogenic properties of patient derived stem cells used in reconstructive surgeries and provide safe and effective enhancement of bone formation in indications for which this is a sig... Read more
Org chart
Sanford J. Madigan
Collapse
Gloria Matthews
Chief Medical Officer
Albert Your
Senior Director, CMC
Stefanie Monica Gaster, Ph.D.
Clinical Program Manager
